Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 77 Prostatic Neoplasms 56 Carcinoma, Non-Small-Cell Lung 49 Breast Neoplasms 49 Esophageal Neoplasms 47 Rectal Neoplasms 41 Lung Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 32 Gliosarcoma 31 Head and Neck Neoplasms 30 Pancreatic Neoplasms 29 Brain Neoplasms 29 Uterine Cervical Neoplasms 27 Neoplasm Metastasis 23 Glioma 23 Neoplasms 22 Oropharyngeal Neoplasms 20 Sarcoma 19 Esophageal Squamous Cell Carcinoma 19 Melanoma 18 Astrocytoma 17 Adenocarcinoma Of Esophagus 15 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Squamous Cell 12 Urinary Bladder Neoplasms 11 Lymphoma, Follicular 11 Central Nervous System Neoplasms 11 Carcinoma 11 Burkitt Lymphoma 10

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 Cetuximab 3 pembrolizumab 2 palbociclib 2 Specimen Handling 2 Radiotherapy 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 tazemetostat 1 spartalizumab 1 relatlimab 1 nilotinib 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Photochemotherapy 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chordoma × Radiation × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡